Rigel Pharmaceuticals (RI2.F) Q3 2024 Earnings

6AugConfirmed
Q2 2024
Q3 2024
-0.47
-0.33
-0.19
-0.05

Details

Expected EPS
-0.26734561548
Actual EPS
-0.054915599999999995
Surprise EPS
0.21
Surprise Percent
+79.46%

Description

Rigel Pharmaceuticals (RI2.F) has reported earnings of -0.054915599999999995 per share for Q3 2024.

0 Comments

Share your thoughts